NYSE
G
Last Price
US $33.86
KEY FIGURES
MKT CAP
$5.7B
EPS
TTM
$3.45
PEG
TTM
0.91x
P/E
TTM
9.83x
P/S
TTM
1.09x
YIELD
2.11%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
22.91%
Return on equity
ROIC: 13.69%
Valuation History
10.1X
Price to Earnings
EV/EBITDA: 7.5X
Cash flow
Profit margin
6.49%
(FY vs FY)
EBITDA Y/Y
7.24%
(FY vs FY)
Cash flow Y/Y
7.42%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $33.86
88.36%
Default assumptions
EBITDA Multiple
Fair Value
Market $33.86
-9.36%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Genpact Limited cash flow to debt ratio of 46.07% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial stability - Healthy cash flow growth.
Genpact Limited's free cash flow has increased 38.56% from $530.19M last year to $734.65M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Genpact Limited's debt to equity ratio is 0.54, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Genpact Limited's debt has decreased relative to shareholder equity from 0.60 last year to 0.54 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Genpact Limited has a net debt to EBITDA ratio of 1.04x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Genpact Limited's interest coverage ratio of 10.68 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Genpact Limited's profit margin has increased (2.99%) in the last year from 10.78% to 11.10%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Genpact Limited's short-term assets of $2.66G exceed its short-term liabilities of $1.60G
Increasing performance - ROA.
Genpact Limited's return on assets of 10.76% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Genpact Limited's return on equity of 22.91%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Genpact Limited's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Genpact Limited had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Genpact Limited has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Genpact Limited has a free cash flow yield of 12.80%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Genpact Limited's yearly earnings has increased 7.56% since last year from $513.67M to $552.49M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Genpact Limited's yearly revenue has increased 6.56% since last year from $4.77G to $5.08G, signaling increasing performance
Increasing performance - ROIC.
ROIC 13.69% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Genpact Limited's 3-year revenue CAGR of 5.14% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Genpact Limited had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Genpact Limited had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
Genpact Limited is undervalued relative to its fair value price of 63.78 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Genpact Limited has an earnings yield of 10.18%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Genpact Limited is overvalued relative to its fair value price of 30.69 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Genpact Limited has an EV/EBITDA ratio of 7.60x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Genpact Limited has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Genpact Limited has a price-to-book ratio of 2.20x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Genpact Limited has a price-to-sales ratio of 1.09x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue